The PVI Company

When pharmaceutical companies and health plans needed a better way to exchange clinical and economic evidence, no standard existed.

We built one.

FormularyDecisions became the industry standard — used by the majority of US health plans to request and access drug evidence from manufacturers.

Now we’re building what comes next.

Nine leaders from payer, pharma, health economics, and technology.

One platform that changes how drugs are valued.

Leadership

The people behind what’s next

Payer executives, pharma leaders, HEOR experts, and the team that built the industry standard.

Healthcare & Technology Entrepreneurs

Allen Lising

Former CEO, Dymaxium & Creator, FormularyDecisions

Built the industry standard for evidence exchange — now redefining how drugs are valued

Mike Carleton

Former CFO, Dymaxium & Operations Executive, Xcenda/Cencora

Scaled healthcare platform from startup to acquisition to expansion

Nikola Cosic

Chief Technology & Innovation Officer

Software and data leadership engineering next-generation AI platforms for healthcare

Payer Leaders

Bridget Olson

Co-Architect, Payer Platforms

Designed the payer experience that became the national standard for drug evidence review

Doug Bourgoyne

Payer Entrepreneur & Former AMCP President

Three decades leading formulary policy and P&T committee governance

Jeff Dunn

Payer Executive & AMCP Board Director

Leading PBM strategy and formulary decision-making at national scale

Pharma & HEOR Experts

Michael Pollock

Former SVP, Market Access & HEOR

Bridging evidence, patient voice, and market strategy across top-tier pharma and biotech organizations

Goran Medic

Director, Market Access & HEOR

Integrating health economics, HTA methodologies, and data to demonstrate value for emerging therapeutics

Louise Perrault

CEO, Global HEOR Consulting

Building the evidence and analytics that shape market access worldwide